Therascreen KRAS RGQ PCR Kit
收藏NIAID Data Ecosystem2026-03-13 收录
官方服务：
资源简介：
An interventional, prospective IVD device study for the testing of DNA extracted from tumor tissue biopsy samples from patients with Colorectal Cancer (CRC) who have previously tested positive for the KRAS G12C mutation for potential inclusion into the Amgen Phase III clinical trial (Protocol No 20190172) to demonstrate clinical performance of the therascreen KRAS RGQ PCR Kit
创建时间：
2022-01-15
